Member Benefits
- Preferred pricing on all Topaz harm reduction strips.
- Dedicated support from the Topaz harm reduction team.
- Partnership opportunities for community distribution initiatives.
- Early access to new analytes and product releases.
These tools support drug checking and harm-reduction education. They are not intended for medical diagnosis or clinical decision-making.
Match the risks you’re seeing with the right tools.
Today's harm reduction programs operate under constant pressure, unpredictable supply, limited resources, and rising demands for community-based response.
The most effective harm reduction tools support program missions. Topaz collaborates with teams to build accessible screening tools that support outreach, strengthen care, and adapts as the supply evolves.
Overdose patterns are shifting with the market:
Designed to reduce guesswork in outreach settings so teams can act with clarity, even when conditions aren’t ideal.
Emerging sedatives like medetomidine are beginning to appear alongside xylazine in opioid samples, with agencies such as NIDA and SAMHSA tracking evolving overdose patterns.
| Pattern/Impact | XYLAZINE | MEDETOMIDINE |
|---|---|---|
| Found alongside opioids like fentanyl | Yes ✅ | Emerging in some regions ⚠️ |
| Associated with prolonged sedation | Yes ✅ | Yes ✅ |
| Linked to hard to heal/severe wounds | Yes ✅ | Still being evaluated ⚠️ |
| Reversed by naloxone | No ❌ | No ❌ |
| Detected by xylazine strips | Yes ✅ | No ❌ |
| Requires its own screening | --- | Yes ✅ |
The Topaz Inner Circle is a preferred purchasing and partnership program built for organizations on the front lines of harm reduction. Members receive priority access to test strips, preferred pricing, and the support needed to keep life-saving tools consistently available in their communities.
Our tests strips are designed to make testing fast, reliable, and accessible in community settings and outreach initiatives.
Tell us what your program is working on. We'll follow up with the right tools, instructions, and support for community-based care.